Mutations Associated with Imatinib Mesylate Resistance - Review. [electronic resource]
Producer: 20191021Description: 617-623 p. digitalISSN:- 1314-2143
- Amino Acid Substitution
- Antineoplastic Agents -- pharmacology
- Drug Resistance, Neoplasm -- genetics
- Fusion Proteins, bcr-abl -- chemistry
- Humans
- Imatinib Mesylate -- pharmacology
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Models, Molecular
- Point Mutation
- Protein Domains
- Protein Kinase Inhibitors -- pharmacology
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.